Copeland Capital Management LLC Purchases 98,984 Shares of U.S. Physical Therapy, Inc. $USPH

Key Points

• Copeland Capital Management increased its U.S. Physical Therapy stake by 11.8% in the third quarter, purchasing 98,984 shares to reach 940,528 shares valued at approximately $80.6 million, or 6.3% of the company.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $98.25; recent targets range from $95 to $98.
• USPH reported quarterly revenue of $214.1 million, up 8.5% year over year, but missed EPS estimates ($0.75 versus $0.81). The company also pays a quarterly dividend of $0.46 per share, representing a 2.1% yield.

Copeland Capital Management LLC grew its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 11.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 940,528 shares of the company's stock after buying an additional 98,984 shares during the quarter. U.S. Physical Therapy makes up about 1.8% of Copeland Capital Management LLC's investment portfolio, making the stock its 5th biggest position. Copeland Capital Management LLC owned 6.30% of U.S. Physical Therapy worth $80,632,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in USPH. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in U.S. Physical Therapy during the 2nd quarter worth approximately $30,000. Integrated Wealth Concepts LLC acquired a new stake in U.S. Physical Therapy during the 2nd quarter valued at $33,000. Parallel Advisors LLC increased its holdings in U.S. Physical Therapy by 75.2% during the 1st quarter. Parallel Advisors LLC now owns 785 shares of the company's stock valued at $59,000 after purchasing an additional 337 shares in the last quarter. HighTower Advisors LLC bought a new position in U.S. Physical Therapy in the 2nd quarter valued at $202,000. Finally, Corient Private Wealth LP bought a new position in U.S. Physical Therapy in the 2nd quarter valued at $212,000.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Citizens Jmp reissued a "market outperform" rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Weiss Ratings restated a "hold (c-)" rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. Barrington Research lifted their price target on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an "outperform" rating in a report on Monday, August 10th. JPMorgan Chase & Co. lifted their price target on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an "overweight" rating in a report on Friday, September 11th. Finally, Citigroup reiterated a "market outperform" rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $98.25.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $85.59 on Wednesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. The firm has a 50 day simple moving average of $81.08 and a 200 day simple moving average of $73.82. U.S. Physical Therapy, Inc. has a fifty-two week low of $58.19 and a fifty-two week high of $93.50. The firm has a market cap of $1.28 billion, a P/E ratio of 503.48, a P/E/G ratio of 2.18 and a beta of 1.12.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.06). The firm had revenue of $214.06 million for the quarter, compared to analyst estimates of $211.36 million. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%. The firm's quarterly revenue was up 8.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.81 EPS. Sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.89 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 11th. Stockholders of record on Friday, August 21st were given a dividend of $0.46 per share. The ex-dividend date was Friday, August 21st. This represents a $1.84 annualized dividend and a dividend yield of 2.1%. U.S. Physical Therapy's payout ratio is currently 1,082.35%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc is a healthcare services company that operates outpatient physical therapy clinics throughout the United States. The company provides rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength or physical function.

In addition to operating clinics, U.S. Physical Therapy develops partnerships with physical therapists and physician groups through management arrangements. The company provides administrative and business support, including billing, information systems, human resources, marketing and compliance services, while clinical care is delivered by licensed healthcare professionals.

The company also provides industrial injury prevention and rehabilitation services to employers and their workforces.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.